Aurora Cannabis ACB
NASDAQ ACB
$3.94 +0.13 (+3.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aurora Cannabis (ACB) Net Equity Issued and Repurchased (2023 - 2024)

Aurora Cannabis (ACB) posted quarterly Net Equity Issued and Repurchased of $92364.7 for Q3 2024, down 92.81% year-over-year from $1.3 million in Q4 2023, and down 99.66% quarter-over-quarter from $27.1 million in Q4 2023.

Aurora Cannabis (ACB) Net Equity Issued and Repurchased (2023 - 2024) Analysis & Trends

Aurora Cannabis (ACB) has reported Net Equity Issued and Repurchased for 2 consecutive years, with $92364.7 the latest figure, recorded in Q3 2024.

  • In Q3 2024, Net Equity Issued and Repurchased fell 92.81% year-over-year to $92364.7; the TTM figure through Dec 2024 stood at $28.4 million (changed N/A YoY), while the FY2023 annual figure was $1.3 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased declined to $92364.7 in Q3 2024 per ACB's latest filing, from $27.1 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $27.1 million in Q4 2023 and bottomed at $92364.7 in Q3 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 700,000.00
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 84.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Aurora Cannabis 243.01 Mn 170.70 Mn 25.75 Mn 4.95 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 92,364.73
Sep 30, 2024 92,364.73
Dec 31, 2023 27.06 Mn
Dec 31, 2023 27.06 Mn
Sep 30, 2023 1.28 Mn
Sep 30, 2023 1.28 Mn